Tag Archives: Glaucoma

Biotech, Doctors, Eye Care, Healthcare, Healthcare Services, Healthcare Solutions, Non-Surgical Procedure, Ophthalmology

8-year follow up results revealed for the ELIOS® Excimer Laser Trabeculostomy procedure combined with cataract surgery

Leave a comment

LOS ANGELES, CA, United States, 17-Feb-2022 — /EPR HEALTHCARE NEWS/ — Elios Vision Inc. announced today 8-year follow up results of its novel ELIOS® Excimer Laser Trabeculostomy procedure combined with cataract surgery.

Key study findings:

  • 161 eyes of 128 patients with glaucoma or ocular hypertension and cataract received Phaco-ELIOS, and were followed over an 8-year period
  • Significant mean IOP reduction from 19.3 mmHg at baseline to 15.4 mmHg after 8 years of follow-up (p=0.0040)
  • Significant reduction in medication requirements
  • Only 3.7% of patients required secondary surgical glaucoma intervention during the 8-year follow-up period
  • No serious intra- or post-operative events were observed

“This large cohort study provides encouraging evidence that the ‘implant free’ Phaco-ELIOS procedure causes minimal trauma, appears to show lasting IOP control with no serious intra- or post-operative complications, and low rate of incisional secondary surgical intervention over a period of at least 8 years,” said Thomas W. Samuelson, MD, founding partner of Minnesota Eye Consultants and an Adjunct Professor of Ophthalmology at the University of Minnesota. Dr Samuelson added that, “it is encouraging for patients that the number of topical medications required to control IOP was reduced significantly up to 4 years and remained below baseline levels across the entire 8-year follow-up period.”

About the ELIOS procedure:

  • The ELIOS procedure creates ten ‘microchannels (210µm)’ in the trabecular meshwork using an excimer laser.
  • The microchannels facilitate aqueous outflow into Schlemm’s canal, the eyes natural outflow pathway, reducing IOP2 and preserving the integrity, structure, and function of the trabecular meshwork.
  • Combining ELIOS with phacoemulsification is an ‘implant free’ minimally invasive glaucoma procedure with a rapid learning curve for ophthalmic surgeons.
  • The ELIOS procedure is approved in Europe for use in adults with glaucoma, with or without cataract, and is undergoing clinical trials in the US under an investigational device exemption (IDE).
  • Data on the ELIOS procedure has been published in 12 clinical studies2 with over 850 eyes treated showing an IOP reduction of 20-40% from baseline, a significant reduction of medication for up to 4 years, and up to 81% of patients ‘medication free’ at 1 year,3 and a favorable safety profile.

Over the past decade minimally invasive glaucoma surgeries (MIGS) have transformed the treatment of mild to moderate glaucoma and are an attractive alternative to more invasive incisional procedures such as trabeculectomy and tube shunts. Despite the growing popularity of MIGS, combining cataract and glaucoma surgery is not yet the preferred choice by most surgeons.

This clinical study shows that the ELIOS procedure is attractive to all ophthalmic surgeons for patients with glaucoma that are not controlled by medications or SLT because it reduces IOP to mid-teens for at least 8 years, minimizes postop inflammation, avoids intraocular implants, has a favorable safety profile, with or without cataract surgery.

Why are these findings relevant?

  • In 2022 it is estimated that around 29 million people globally will undergo cataract removal and around 20% also have glaucoma or ocular hypertension4.
  • These findings demonstrate a sustained reduction of IOP that is longer than any other currently available MIGS procedure.
  • Routinely combining cataract and glaucoma treatment is appealing since it can reduce the undesirable burden and side effects of drops and it can avoid patients undergoing two separate surgical procedures which also is more efficient for healthcare systems.

SOURCE: EuropaWire

Diagnostics, Diseases, Doctors, Eye Care, Healthcare, Medicine, Ophthalmology, Society

Barack Obama Signs Proclamation Save Your Vision Week 2009 – BiCOM with Glaucoma Eye Test Diaton is Preparing to Help

Barack Obama, President of the United States of America proclaims March 1 through March 7, 2009, as Save Your Vision Week. BiCOM Inc home of Glaucoma Eye Test Diaton – non-contact Glaucoma Eye Test through the Eyelid is prepared to assist with vision screenings. Roman Iospa, CEO of BiCOM comments on Presidents support of glaucoma screenings. Early diagnosis and timely treatment are critical to minimize vision loss from eye diseases.

Proclamation by the president of the United Stated of America addresses the important issue of Blindness and visual impairment that affects millions of Americans. Early diagnosis and timely treatment are critical to minimize vision loss from eye diseases. During Save Your Vision Week – Barack Obama encourages all Americans to take action to prevent their vision loss.

BiCOM Inc. home of Glaucoma Eye Test Diaton Tonometer (IOP through the Eyelid), has been a long supporter of preventive glaucoma screenings. At a recent free glaucoma screening event where BiCOM in conjunction with SAVE Program (Sight for a Vision Exchange) and The Congressional Glaucoma Caucus Foundation conducted at New York City Children’s Services in honor of African American Heritage Celebration has revealed many with elevated intraocular pressure (IOP) a major risk factor for glaucoma. Patients were referred to an ophthalmologist Dr. Lynnette P. Williams-Young a glaucoma specialist for further evaluation.

Unfortunately, most people have limited knowledge of blinding eye disorders. Based on National Eye Institute 2005 study, only eight percent of respondents knew that glaucoma, a condition that can damage the optic nerve and cause vision loss and blindness, strikes without early warning. Similarly, glaucoma also begins as a silent vision threat; as per Prevent Blindness America, it is estimated that of those Americans that have glaucoma, only half know they have it. It is estimated that 60 million Americans are at risk for developing glaucoma.

Everyone should be screened, especially with availability of new non-invasive (over the eyelid) glaucoma screening technology aka “Glaucoma Eye Test” Diaton tonometer available to optometrists, ophthalmologists and general physicians, enabling doctors to quickly and painlessly screen individuals at risk.

Several demographic groups are at higher risk for visual impairment, including teenagers, diabetics, Hispanics, African Americans, and the economically disadvantaged. Older Americans are more susceptible to eye conditions such as age-related macular degeneration, diabetic retinopathy, and glaucoma. Children need regular vision screenings because vision disorders left untreated during childhood can lead to permanent visual impairment during adulthood.

President Obama stated, “Eye disease knows no bounds, and every American should take steps to protect his or her eyesight.”

To remind Americans about the importance of safeguarding their eyesight, the Congress, by joint resolution approved December 30, 1963, as amended (77 Stat. 629; 36 U.S.C. 138), has authorized and requested the President to proclaim the first week in March of each year as “Save Your Vision Week.”

“I’m pleased to see that President Barack Obama, with only weeks in the office is addressing an important issue of blindness, its early detection and timely treatment. My whole team at BiCOM Inc., and our partners are ready to continue our efforts and act on a larger scale by reaching out to many more people through awareness, training, glaucoma screening events and making “Glaucoma Eye Test” Diaton tonometer available to all that are willing to participate,“ said Roman Iospa, CEO of BiCOM Inc.

From the website of the White House:http://www.whitehouse.gov/the_press_office/Save-Your-Vision-Week-2009/

“NOW, THEREFORE, I, BARACK OBAMA, President of the United States of America, do hereby proclaim March 1 through March 7, 2009, as Save Your Vision Week. During this time, I invite eye care professionals, teachers, members of the media, and all organizations dedicated to preserving eyesight to join in activities that will raise awareness of vision diseases and disorders.”

About BiCOM Inc:
BiCOM, with its 15 years of tradition and global clientele, has proven to be the enterprise of the highest level of professionalism, integrity and financial solvency. A unique team of engineers, medical, legal and business experts makes BiCOM Inc. the right place for global talent to find support and guidance. BiCOM Inc. sees its mission in bringing to market innovative products developed and manufactured worldwide. More about Diaton tonometer: TonometerDiaton.com

BiCOM represents and supports Glaucoma Eye Test aka Diaton tonometers in over 50 countries and growing. BiCOM conducts Free Glaucoma Screening Events throughout the Globe.
BiCOM-Ophthalmic.com

Via EPR Network
More Healthcare press releases

Doctors, Eye Care, Health Reform, Healthcare, Healthcare Information, Healthcare Professionals, Medicine, Society

Glaucoma is the leading cause of preventable blindness worldwide. 60 million Americans are at RISK for developing Glaucoma

Dr. Lynnette Williams-Young, S.A.V.E Program Coordinator, in conjunction with National Glaucoma Awareness with support from Park Avenue Laser Vision, Dr. Emil Chynn and Roman Iospa, CEO of BiCOM Inc., home of Glaucoma Eye Test, are providing free Glaucoma screening events for the whole community.

Prevent Blindness America Survey found that:

  • Blindness ranked third (after cancer and heart disease) as people’s major fear.
  • It is estimated that over 4 million Americans have glaucoma but only half of those know they have it.
  • Glaucoma is 6 to 8 times more common in African-Americans than Caucasians.
  • Everyone is at risk for glaucoma from babies to senior citizens. Yes, older people are at a higher risk for glaucoma but babies can be born with glaucoma (approximately 1 out of every 10,000 babies born in the United States).

National Glaucoma Awareness Month presents an opportunity to educate and screen those most at risk for developing the “sneak thief of sight”. Dr.Williams-Young is the coordinator for the S.A.V.E program.

The “Sight for A Vision Exchange” is a program inspired by Sis. Mae McGill and Bishop James Gaylord and developed by Dr. Chynn and Dr. Williams-Young to raise $50,000 to benefit the Capital Stewardship Campaign of Kelly Temple Church.

Through the partnership between Park Avenue Laser Vision Center and Kelly Temple, we will be able to provide quality affordable laser vision correction for church members. Also, we will be able to provide education about laser vision correction and educate about maintaining a lifetime of good ocular health. Ultimately, this will reduce the fear of laser vision correction in the African American community.

Glaucoma screenings will be performed with BiCOM’s non-invasive, through the eyelid Tonometer Diaton (www.GlaucomaEyeTest.com) – the newest, safest way to screen for high intraocular pressure (IOP), which can be an indication of Glaucoma.

Join us for a free eye pressure screenings at Park Avenue Laser Vision 102 East 25th Street (& Park Avenue South). Call Park Avenue Laser Vision with any questions and directions at 212-741-8628.

About “Sight For A Vision Exchange” (S.A.V.E) – The objective of S.A.V.E is to provide affordable laser vision correction for church members, provide education about laser vision correction and reduce fear of laser vision correction in the African-American community.

About Park Avenue Laser Vision – New York’s Only No-Flap, All-Laser Vision Correction. http://www.ParkAvenueLaser.com

About BiCOM Inc. – BiCOM Inc. home of Tonometer Diaton a.k.a “Glaucoma Eye Test” allows to safely screen for intraocular pressure through the eyelid. BiCOM Inc. is a continued supporter of Glaucoma screening / educational programs nationally and internationally. More: http://www.TonometerDiaton.com

Via EPR Network
More Healthcare press releases

Healthcare, Healthcare Solutions, Ophthalmology, Public Health, Society

Diaton Tonometer Allows Glaucoma Screening To Be Done Simply, Quickly And Painlessly

Driving is a demanding activity. Drivers must see obstacles or hazards, straight ahead or in their peripheral visual field, consider the possible reactions of others, estimate the time and distance, decide upon their action and then react accordingly. Driving safety depends on many external factors as well as the condition of the driver.

Visual impairment is one of the factors in the decision to deny a person the right to drive. Losing one’s driving license is a major limitation in their lifestyle and day to day routine. Because vision is the most important factor during driving, many driving related injuries are a result of vision problems.

As per Survey of Ophthalmology, “visual acuity is related to crash involvement, whereas peripheral vision appears to play a more critical role.” One of such visual impairments may be caused by glaucoma. Glaucoma is characterized by abnormally high intraocular pressure (IOP), the pressure inside the eye. This can cause a loss of peripheral vision, which makes it more difficult to see a pedestrian or vehicle approaching from the side; in
essence creating a large blind spot.

Vision loss due to glaucoma is irreversible. However, increased intraocular (eye) pressure (IOP) is easy to screen for and detect in early stages, allowing the prevention of any further loss of sight. Routine screening can be performed by your general physician or eye care professional.

BiCOM Inc. with its unique new screening device, Diaton Tonometer, now allows this eye test to be done simply, quickly and painlessly. The Diaton Tonometermeasures intraocular pressure (IOP) Through the Eyelid, avoiding the commonly known discomfort of screening through the cornea. For the first time,Diaton Tonometry requires no contact with the cornea. Measurement is done through the upper eye lid, over the sclera, eliminating any risk of infection or discomfort.

“Too many people believe they can tell if they’re developing glaucoma,” says Dr. Gregory K. Harmon, Chairman of the Glaucoma Foundation. However, it is estimated that half of those suffering damage from glaucoma, do not know they have it. The disease has come to be called the “silent thief of sight” because it often strikes without any symptoms.

A peripheral impairment of the visual field is a reason for denying a driving license in most states in the USA. For many who do not experience any visual symptoms, it comes as a shock when they are denied renewal of their drivers license based on visual field defect or poor peripheral vision.

Patients with visual field defects, commonly due to glaucoma, have double the incidence of road accidents or traffic violations as compared to those with a full visual field according to a study by Johnson & Keltner. More importantly, almost half of those with visual field loss were unaware of any problem with peripheral vision.

You cannot influence the risk factors for glaucoma. However, you can take measures to detect the problem at an early stage and stop any further damage to your vision. Doing so will prevent it from affecting your driving safety and interfering with your routine lifestyle. Ask your doctor about routine glaucoma screening with the Diaton Tonometer, even if you think your vision is normal. Problems may be easier to correct if caught at an early stage.

About BiCOM Inc.
BiCOM, with its 15 years of tradition and global clientele, has proven to be the enterprise of the highest level of professionalism, integrity and financial solvency. A unique team of engineers, medical, legal and business experts makes BiCOM Inc. the right place for global talent to find support and guidance. BiCOM Inc. sees its mission in bringing to market innovative products developed and manufactured worldwide.

As of January 2008, BiCOM represents and supports Diaton tonometer in over 30 countries and growing with each day…

Says Mr. Boris Kun, President of BiCOM Inc: “Diaton Tonometer is a revolutionary device and signifies a new stage in Optometry and Ophthalmology!”

BiCOM Inc., with a release of tonometer Diaton to US is committing to a mission of preventing blindness caused by glaucoma.

Via EPR Network
More Healthcare press releases